OMA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.683170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.339800E-01
Normal-vs-Stage2
2.082200E-01
Normal-vs-Stage3
2.270000E-01
Normal-vs-Stage4
8.014200E-01
Stage1-vs-Stage2
8.076800E-01
Stage1-vs-Stage3
1.568170E-01
Stage1-vs-Stage4
2.435600E-01
Stage2-vs-Stage3
6.580300E-02
Stage2-vs-Stage4
5.297700E-02
Stage3-vs-Stage4
2.276100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.533840E-01
Normal-vs-AfricanAmerican
4.075600E-01
Normal-vs-Asian
5.508400E-01
Caucasian-vs-AfricanAmerican
8.913400E-01
Caucasian-vs-Asian
6.082400E-01
AfricanAmerican-vs-Asian
6.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.404580E-01
Normal-vs-Female
2.258800E-01
Male-vs-Female
5.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.903200E-01
Normal-vs-Age(41-60Yrs)
2.122000E-01
Normal-vs-Age(61-80Yrs)
1.624210E-01
Normal-vs-Age(81-100Yrs)
3.740000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.074600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.253600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.617200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.948560E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.188600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.684200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.347800E-01
Normal-vs-Daily Drinker
2.748000E-01
Normal-vs-Weekly Drinker
1.113020E-01
Normal-vs-Occasional Drinker
5.006800E-01
Normal-vs-Social Drinker
5.291600E-01
Non Drinker-vs-Daily Drinker
4.516800E-01
Non Drinker-vs-Weekly Drinker
1.266450E-01
Non Drinker-vs-Occasional Drinker
5.286000E-01
Non Drinker-vs-Social Drinker
8.253000E-01
Daily Drinker-vs-Weekly Drinker
4.953400E-01
Daily Drinker-vs-Occasional Drinker
2.345000E-01
Daily Drinker-vs-Social Drinker
5.894600E-01
Weekly Drinker-vs-Occasional Drinker
4.939600E-02
Weekly Drinker-vs-Social Drinker
1.655630E-01
Occasional Drinker-vs-Social Drinker
3.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.998100E-02
Normal-vs-Grade 2
3.359700E-02
Normal-vs-Grade 3
1.228030E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.976000E-04
Grade 1-vs-Grade 3
8.625000E-03
Grade 1-vs-Grade 4
7.998100E-02
Grade 2-vs-Grade 3
3.301200E-01
Grade 2-vs-Grade 4
3.359700E-02
Grade 3-vs-Grade 4
1.228030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.254400E-01
Normal-vs-NonDiabetic
1.289550E-01
Diabetic-vs-NonDiabetic
6.371800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.933200E-01
Normal-vs-NoPancreatitis
1.512630E-01
Pancreatitis-vs-NoPancreatitis
2.385000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.182400E-01
Normal-vs-N1
1.757790E-01
N0-vs-N1
9.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.086600E-01
Normal-vs-TP53-NonMutant
3.773600E-01
TP53-Mutant-vs-TP53-NonMutant
3.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
